Christine Scheve

As chief science officer of Nano, Christine oversees the company’s efforts to track and understand the molecular interplay between data from the world around us and within us in the context of our everyday lives. Her background, which spans tissue engineering, drug delivery, molecular biophysics and nanotechnology, gives her unique insight into the value of this data and its implications for the future of human health. She previously served as an advisor to science and technology startups at Powershift Group, a venture development firm, and worked at a top-level clinical, regulatory and quality consulting firm specializing in medical and in-vitro diagnostic devices. Christine began her career as a research scientist at the University of Texas at Austin where she specialized in molecular biophysics and nanotechnology. She has also conducted research at The Methodist Hospital Research Institute and was a recipient of the Waterloo Institute of Nanotechnology Fellowship at The University of Waterloo in Canada. She has authored several peer-reviewed publications and holds a bachelor’s and a master’s degree in biomedical engineering from the University of Texas at Austin.